Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Oragenics, Inc.

AMEX: OGENHealthcare / Biotechnology / USA
0.9300+0.0300+3.33%Vol 900 8281Y Perf -50.31%
Feb 21st, 2019 16:00
BID0.9300 ASK0.9300
Open0.9100 Previous Close0.9000
Pre-Market0.92 After-Trading0.93
 0.02 2.22%  - -%
Target Price
5.00 
Analyst Rating
— 0.00
Potencial %
437.63 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★★★+ —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)27 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
14.40 
Earnings Date
22nd Feb 2019

Today's Price Range

0.90000.9400

 

52wk Range

0.38004.20

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
1.09%
3 Months
16.25%
6 Months
116.28%
1 Year
-50.31%
3 Years
-91.39%
5 Years
-97.25%

Quotes

Name / TickerPriceChg.Chg.%
OGEN0.93000.03003.33
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
8.90
Current Ratio
9.90
Long Term Debt to Total Capital
-
Total Debt to Equity
0.03
Interest Coverage
-154.60
Leverage Ratio 8.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
3.66
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-4.30
Cash Flow Per Share
-1.07
Price to Tangible Book
3.66
Book Value per Share
0.24
Enterprise Value (in ths.)
19 388
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-128.60
ROE last 12 Months
-289.29
Return on Assets (5Y Avg)
-89.13
ROA last 12 Months
-97.30
Return on Capital (5Y Avg)
-242.92
ROC last 12 Months
-275.68
Return on invested Capital Q
-169.55
Return on invested Capital Y
-418.39
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.22-0.35-59.09
Q02 2018-0.41-0.387.32
Q02 2017--0.20-
Q01 2017--0.40-
Q03 2016-0.04-0.040.00
Q02 2016--0.05-
Q01 2016--0.05-
Q04 2015--0.06-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.1726.09Positive
12/2018 FY-0.8212.77Positive
3/2019 QR-0.250.00-
12/2019 FY-0.6116.44Positive
Next Report Date22nd Feb 2019
Estimated EPS Next Report-0.17
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume900 828
Shares Outstanding (in ths.)29 433
Trades Count1 008
Dollar Volume742 790
Avg. Volume1 345 886
Avg. Weekly Volume1 164 081
Avg. Monthly Volume1 053 520
Avg. Quarterly Volume2 119 148

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

18%82%

Bearish Bullish

48%52%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News